| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Royalty Pharma Plc (RPRX) has 15 insiders with recent SEC Form 4 filings, including 4 buys and 16 sells. RPRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 941.0K | $47.79M | - | |
| VP | 658.5K | $33.45M | - | |
| Dir | 194.8K | $9.90M | - | |
| Dir | 81.4K | $4.13M | - | |
| ? | 73.1K | $3.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2021 | Reddoch James F.66 | EVP, Research &Investments | Sell | 43,927 | $46.32 | $2,034,518.54 | -14.6% | -5.8% | -14.1% | |
| Mar 3, 2021 | Coyne Terrance P.75 | EVP &CFO | Sell | 100,000 | $44.78 | $4,478,450.32 | -10.2% | - | - | |
| Mar 2, 2021 | Coyne Terrance P.75 | EVP &CFO | Sell | 100,000 | $46.94 | $4,694,090.14 | -14.2% | - | - | |
| Mar 2, 2021 | Lloyd George W.71 | EVP, Investments &GC | Sell | 125,000 | $46.94 | $5,867,148.21 | -14.2% | - | - | |
| Mar 2, 2021 | Reddoch James F.66 | EVP, Research &Investments | Sell | 100,000 | $46.92 | $4,692,158.19 | -14.2% | - | - | |
| Feb 25, 2021 | Fernandez Henry A48 | Director | Buy | 25,700 | $46.83 | $1,203,479.60 | New | - | - | |
| Dec 18, 2020 | Adage Capital Partners Gp, L.l.c.64 | 10% Owner | Sell | 7,301,050 | $43.92 | $320,672,221.00 | -8.6% | - | - | |
| Oct 20, 2020 | Riggs Rory B67 | Director | Sell | 463,200 | $42.00 | $19,454,400.00 | -100% | - | - | |
| Jun 18, 2020 | Adage Capital Partners Gp, L.l.c.64 | 10% Owner | Buy | 3,000,000 | $28.00 | $84,000,000.00 | +7.0% | - | - | |
| Jun 18, 2020 | Lloyd George W.71 | EVP, Investments &GC | Buy | 14,200 | $28.00 | $397,600.00 | New | - | - |